ArticleCancer immunology, immunotherapy : CII2020

ADRB3 expression in tumor cells is a poor prognostic factor and promotes proliferation in non-small cell lung carcinoma.

Meng Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.